FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 103 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $249,000 | -71.7% | 14,641 | -92.2% | 0.00% | -77.8% |
| Q3 2020 | $881,000 | -33.5% | 187,497 | -13.6% | 0.01% | -35.7% |
| Q2 2020 | $1,324,000 | +4992.3% | 216,991 | +1800.9% | 0.01% | – |
| Q1 2020 | $26,000 | -98.4% | 11,415 | -96.8% | 0.00% | -100.0% |
| Q4 2019 | $1,658,000 | +252.8% | 361,299 | +198.0% | 0.02% | +166.7% |
| Q3 2019 | $470,000 | +103.5% | 121,243 | +216.9% | 0.01% | +100.0% |
| Q2 2019 | $231,000 | -74.6% | 38,260 | -43.7% | 0.00% | -76.9% |
| Q1 2019 | $910,000 | +79.8% | 67,947 | +24.8% | 0.01% | +44.4% |
| Q4 2018 | $506,000 | -33.2% | 54,447 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $758,000 | +9.1% | 54,447 | +23.8% | 0.01% | 0.0% |
| Q2 2018 | $695,000 | +44.5% | 43,990 | +57.2% | 0.01% | +37.5% |
| Q1 2018 | $481,000 | -4.6% | 27,990 | +21.7% | 0.01% | -11.1% |
| Q4 2017 | $504,000 | – | 22,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|